Biomarkers of progressive supranuclear palsy identified in spinal fluid
The recent discovery of a unique protein pattern in spinal fluid may make earlier diagnosis of progressive supranuclear palsy a reality.
Researchers at the University of California San Francisco (CA, USA) have identified a pattern of proteins in cerebral spinal fluid that is indicative of progressive supranuclear palsy (PSP), a neurological disorder that usually goes undiagnosed until after an individual dies. Discovering the fluid biomarkers of PSP is the first step in not only earlier diagnosis but also in developing targeted therapeutics for the elusive neurological condition.
